dpollo@hotmail.com | |

Why Should Phase 1 Cancer Trial Participation and Optimal End-of-Life Care Be Incompatible?

Escrito por orixwp el . Posteado en Artículos PubMed

Related Articles Why Should Phase 1 Cancer Trial Participation and Optimal End-of-Life Care Be Incompatible? Oncology. 2017;92(1):1-2 Authors: Markman M PMID: 27923224 [PubMed – indexed for MEDLINE]
Origen: Why Should Phase 1 Cancer Trial Participation and Optimal End-of-Life Care Be Incompatible? – PubMed

Etiquetas:

orixwp

This information box about the author only appears if the author has biographical information. Otherwise there is not author box shown. Follow YOOtheme on Twitter or read the blog.


Blog

Síguenos en:

Colaboradores

Search